Evaluation of effective dose for a patient under Ga-67 nuclear examination using TLD, water phantom and a simplified model

Journal of Radiation Research

Volumn 53, Issue 6, 2012, Pages 989-998

  Chu, Kuang Hua ^a,b   Lin, Yu Ting ^a,c   Hsu, Chia Chun ^a,d   Chen, Chien Yi ^e   Pan, Lung Kwang ^a  

^a NATIONAL YUNLIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

dose verification; internal dose; TLD; Transient equilibrium; water phantom

Indexed keywords

GALLIUM COMPOUNDS; GAMMA RAYS; WATER;

CITRATE SOLUTIONS; DOSE VERIFICATION; EFFECTIVE DOSE; GAMMA-CAMERA; HALF LIVES; INTERNAL DOSE; PHANTOMS; THERMOLUMINESCENT-DOSIMETERS; TRANSIENT EQUILIBRIUM; WATER PHANTOM;

PHANTOMS;

EID: 84869995519     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrs050     Document Type: Article

References (31)

1. Fisher DR. Internal dosimetry for systemic radiation therapy. Semin Radiat Oncol 2000;10(2):123-32. (Pubitemid 30205493)
2. Yasar D, Tugrul AB. A new approach for the calculation of critical organ dose in nuclear applications. Appl Radiat Isotopes 2005;62:405-10. (Pubitemid 39655919)
3. Yasar D, Tugrul AB. A comparison of TLD measurements to MIRD estimates of the dose to the tests from Tc-99m in the liver and spleen. Radiat Meas 2003;37:113-18.
4. Erwin WD, Groch MW, Macey DJ et al. A radioimmunoimaging and MIRD dosimetry treatment planning program for radio immunotherapy. Nucl Med Biol 1996;23 (4):525-2. (Pubitemid 26233227)
5. Flynn AA, Green AJ, Boxer GM et al. A novel technique, using radioluminography, for the measurement of uniformity of radiolabelled antibody distribution in a colorectal cancer xenograft model. Int J Radiat Oncol 1999;43(1):183-9. (Pubitemid 29065843)
6. Kim J, Kim J, Kim C et al. Calculating specific absorbed fractions with standard Korean male adults. Radiat Meas 2010;45(1):103-9.
7. Stabin MG, Tagesson M, Thomas SR et al. Radiation dosimetry in nuclear medicine Appl Radiat Isotopes 1999;50 (1):73-87. (Pubitemid 29048992)
8. Furhang EE, Sgouros G, Chui CS. Radionuclide photon dose kernels for internal emitter dosimetry. Med Phys 1996;23:759-64. (Pubitemid 26155174)
9. Stabin MG. Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk. J Nucl Med 2008;49(9):1555-63.
10. Thomas SR, Gelfand MJ, Burns GS et al. Radiation absorbed dose estimates for the liver, spleen and metaphyseal growth complexes in children undergoing Ga-67 citrate scanning. Radiology 1983;146:817-20. (Pubitemid 13194835)
11. Smith T. Internal exposure of patients and staff in diagnostic nuclear medicine procedures. L Soc Radiol Prot 1984;4:45-51.
12. Saha GB. Fundamentals of Nuclear Pharmacy. New York: Springer-Verlag, 1992.
13. Stabin MG. Health concerns related to radiation exposure of the female nuclear medicine patient. Environ Health Persp 1997;105(6):1403-9. (Pubitemid 28050930)
14. Shanehsazzadeh S, Jalilian AR, Sadeghi HR et al. Determination of human absorbed dose of 67Ga-DTPAACTH based on distribution data in rats. Radiat Prot Dosim 2009;134(2):79-86.
15. UNSCEAR, United Nations Scientific Committee on the Effects of Atomic Radiation. Report of United Nations Scientific Committee on the Effects of Atomic Radiation, Vol. I, INDEX D, 2000.
16. Zuckier LS, Moadel-Sernick RM. Radiolabeled monoclonal antibodies: Imaging, Nuclear Oncology: Diagnosis and Therapy. Philadelphia: Lippincott, Williams & Wilkins, 2001, pp. 83-92.
17. ICRP-60. Recommendations of the International Commission on Radiological Protection Technical Report ICRP-60. International Commission on Radiation Protection, 1991.
18. ICRP-26. Recommendations of the International Commission on Radiological Protection Technical Report ICRP-26. International Commission on Radiation Protection, 1977.
19. Arsos G, Moralidis E, Tsechelidis I et al. Measurement of glomerular filtration rate with chromium-51 ethylene diamino tetraacetic acid in the presence of gallium-67 citrate: a novel method for the solution of the problem. Nucl Med Commun 2011;32(3):221-6.
20. Priest ND, Newton D, Day JP et al. Human metabolism of aluminium-26 and gallium-67 injected as citrates. Hum Exp Toxicol 1995;14(3):287-93.
21. Attix FH. Introduction to Radiological Physics and Radiation Dosimetry. New York: John Wiley and Sons, 1986.
22. MCNP. A General Monte Carlo N-Particle Transport Code, V5, Los Alamos National Laboratory, 2003.
23. Chen CY, Chen HH, Liu KC et al. Optimizing the TLD-100 readout system for various radiotherapy beam doses using the Taguchi methodology. Appl Radiat Isotopes 2010;68(3):481-8.
24. ICRU-48. Phantoms and computational models in therapy, diagnosis and protection ICRU-48. Bethesda: International Commission on Radiation Units and Measurement, 1992.
25. Tanner JE, Piper RK, Leonowich JA et al. Verification of an effective dose equivalent model for neutron. Radiat Prot Dosim 1992;44:171-4.
26. MIRDOSE 3. Radiation Internal Dose Information Center (RIDIC), Oak Ridge Institute For Science and Education (ORISE), 1987.
27. Shanehsazzadeh S, Lahooti A, Sadeghi HR et al. Estimation of human effective absorbed dose of 67Ga-cDTPA-gonadorelin based on biodistribution rat data. Nucl Med Commun 2011;32(1):37-43.
28. MIRD Dose Estimate Report No. 2. Radiation absorbed dose for Ga-66, Ga-67, Ga-68 and Ga-72 citrate. J Nucl Med 1973;14:755-6.
29. Society of Nuclear Medicine. Society of Nuclear Medicine Procedure Guideline for Gallium Scintigraphy in Inflammation Version 3.0, approved June 2, 2004. http://interactive.snm.org/ docs/Gallium-Scintigraphy-in-Inflammation-v3. pdf.
30. Turner JE. Atoms, Radiation and Radiation Protection, 3rd Edition. New York: John Wiley & Sons, Inc., 2007.
31. Chu TC, Lin SY, Hsu CC et al. The response of a thermoluminescent dosimeter to low energy protons in the range 30-100keV. Appl Radiat Isotopes 2001;55(5):679-84.